Volatile inhalational anesthetic

This page covers all Volatile inhalational anesthetic drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting GABA receptors, NMDA receptors, potassium channels, GABA-A receptor, NMDA glutamate receptor, GABA-A receptor, NMDA receptor.

Targets

GABA receptors, NMDA receptors, potassium channels · GABA-A receptor, NMDA glutamate receptor · GABA-A receptor, NMDA receptor

Marketed (2)

• Desflurane Inhalant Product · Sichuan Provincial People's Hospital · Anesthesiology
  Desflurane is a volatile anesthetic that depresses the central nervous system by enhancing inhibitory GABA neurotransmission and inhibiting excitatory glutamate signaling.
• Sevoflurane inhalant product · Sunnybrook Health Sciences Centre · Anesthesiology
  Sevoflurane is a volatile anesthetic that depresses the central nervous system by enhancing inhibitory GABA neurotransmission and inhibiting excitatory glutamate signaling.

Phase 3 pipeline (1)

• Isoflurane Inhalant Product · Sunnybrook Health Sciences Centre · Anesthesiology
  Isoflurane is a volatile anesthetic that depresses the central nervous system by enhancing inhibitory neurotransmission and suppressing excitatory pathways, producing unconsciousness and analgesia.